Asia Pacific In Vitro Diagnostics (IVD) Quality Control Market (2025-2030)
The Asia Pacific In Vitro Diagnostics (IVD) Quality Control Market was valued at $18.9 Million in 2025 and projected to reach to $21.9 Million by 2030, representing a compound annual growth rate of CAGR 3.0%. The Asia Pacific IVD Quality Control Market is experiencing steady growth as healthcare systems across the region prioritize diagnostic accuracy and laboratory standardization.
Asia Pacific In Vitro Diagnostics (IVD) Quality Control Market Trends and Insights
- Rest Of Latin America represents a developing segment within the broader Latin American IVD landscape, where diagnostic laboratories and healthcare facilities are increasingly adopting standardized quality control protocols to ensure test accuracy and regulatory compliance.
- The market in Rest Of Latin America is driven by rising healthcare infrastructure investments, growing demand for reliable diagnostic testing, and strengthening regulatory frameworks that mandate quality assurance in clinical laboratories. Rest Of Latin America's IVD Quality Control Market reflects moderate but steady growth as regional healthcare systems modernize and expand laboratory capabilities.
- The region's market dynamics are shaped by cost-conscious procurement strategies, limited but growing awareness of quality standards, and the gradual adoption of automated quality control solutions.
- Rest Of Latin America continues to lag behind more developed Latin American markets, yet the region presents emerging opportunities as diagnostic volumes increase and healthcare providers prioritize test reliability and patient safety outcomes..
Key Market Statistics
- CAGR (2025-2030) CAGR 3.0%
- Market Size, 2025 ~USD 18.9 Million
- Forecast, 2030 ~USD 21.9 Million
- Geography Asia Pacific
Asia Pacific In Vitro Diagnostics (IVD) Quality Control Market Overview
Market Size & Growth :
Asia Pacific's IVD Quality Control Market is valued at USD 18.9 million in 2025 and is projected to reach USD 21.9 million by 2030, growing at a CAGR of 3.0%, reflecting steady expansion in diagnostic quality assurance infrastructure.
China's Market Leadership :
China dominates the Asia Pacific region with a market size of USD 157.4 million, driven by rapid healthcare modernization, increased laboratory automation, and stringent regulatory requirements for diagnostic accuracy.
Japan's Advanced Diagnostics Sector :
Japan represents a mature market valued at USD 103.9 million, characterized by high adoption of advanced IVD quality control technologies and strong emphasis on precision medicine and laboratory standardization.
Emerging Growth in India :
India's IVD Quality Control Market is valued at USD 58.6 million, with significant growth potential driven by expanding diagnostic laboratory networks, increasing healthcare accessibility, and rising demand for quality assurance in emerging diagnostic centers.
Asia Pacific In Vitro Diagnostics (IVD) Quality Control Market Dynamics
- China and Japan lead the market with advanced infrastructure and regulatory compliance frameworks, while India presents substantial growth opportunities due to expanding diagnostic networks and healthcare modernization initiatives.
- The region's 3.0% CAGR reflects increasing investments in laboratory quality management systems and rising awareness of diagnostic reliability standards. Key drivers include regulatory harmonization efforts, growing laboratory accreditation requirements, and technological advancement in quality control instrumentation.
- Asia Pacific's developing economies are progressively adopting international quality standards, creating demand for comprehensive IVD quality control solutions.
- Strategic partnerships between diagnostic providers and quality assurance vendors are expected to accelerate market penetration across emerging markets in the region..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- Rest Of Latin America's IVD Quality Control Market is valued at USD 18.9 million in 2025 and will grow to USD 21.9 million by 2030 at a 3.0% CAGR.
- Rest Of Latin America exhibits slower growth compared to the global market (5.5% CAGR), reflecting lower healthcare spending and infrastructure maturity in the region.
- Rest Of Latin America's market is driven by regulatory compliance requirements, laboratory modernization, and increasing diagnostic testing volumes across the region.
- Rest Of Latin America presents emerging opportunities as healthcare providers invest in quality assurance infrastructure and adopt standardized diagnostic protocols.
In Vitro Diagnostics (IVD) Quality Control Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | MOLECULAR DIAGNOSTICS (Technology) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 5.5% from 2025 to 2030 |
| Largest Segment | QUALITY CONTROL PRODUCTS (Product & Service) |
| Market Size Base Year (Billions) | ~USD 1.65 (2025) |
| Revenue Forecast (Billions) | ~USD 2.15 (2030) |
| Segments Covered | Product & Service, Type, Technology, Manufacturer Type, End User |
Asia Pacific In Vitro Diagnostics (IVD) Quality Control Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product & Service
- Data Management Solutions
- Quality Assurance Services
- Quality Control Products
By Type
- Independent Controls
- Instrument-Specific Controls
- Other Controls
- Serum/Plasma-Based Controls
- Urine-Based Controls
- Whole Blood-Based Controls
By Technology
- Clinical Chemistry
- Coagulation & Hemostasis
- Hematology
- Immunoassays
- Microbiology
- Molecular Diagnostics
- Other Technologies
By Manufacturer Type
- Original Equipment Manufacturer Controls
- Third-Party Controls
By End User
- Academic & Research Institutes
- Clinical Laboratories
- Hospitals
- Other End Users
Target Audience
- Diagnostic Equipment Manufacturers : Manufacturers need Asia Pacific market intelligence to develop region-specific IVD quality control solutions aligned with local regulatory standards and laboratory infrastructure capabilities across diverse markets.
- Laboratory Service Providers : Diagnostic laboratories and pathology centers require market insights to implement appropriate quality control systems, understand competitive offerings, and optimize operational compliance across Asia Pacific regions.
- Healthcare System Administrators : Hospital networks and healthcare administrators need market data to evaluate quality control technology investments, benchmark against regional standards, and enhance diagnostic accuracy across their facilities.
- Quality Assurance Consultants : QA professionals and consultants require detailed market analysis to advise clients on best practices, emerging technologies, and regulatory compliance strategies specific to Asia Pacific diagnostic markets.
- Investment & Business Development Teams : Investors and business development professionals need comprehensive market forecasts and regional growth projections to identify acquisition targets, partnership opportunities, and expansion strategies in Asia Pacific.
Key Companies in the Asia Pacific In Vitro Diagnostics (IVD) Quality Control Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| BIOMERIEUX S.A. | France | Public Company | Clinical microbiology (VITEK, culture media, ID/AST, BACT/ALERT),Syndromic and molecular diagnostics (BIOFIRE, SPOTFIRE, ARGENE, NUCLISENS),Immunoassays and biomarkers (VIDAS, Hybiome CLIA, sepsis markers), |
| CEPHEID INC. | United States | Private Company | GeneXpert instruments and Xpert test cartridges,SmartCycler systems and assays,Collaborative and program-based solutions (e.g., TB, Ebola, USPS BDS), |
| IMMUCOR, INC. | United States | Private Company | Transfusion (serology instruments and reagents),Transplant & Molecular (HLA, HEA/HPA typing, Array Imaging System),Platelet-focused and specialty coagulation products, |
| DIASORIN | Italy | Public Company | Immunodiagnostics – Infectious and Gastrointestinal Diseases,Immunodiagnostics – Endocrinology and Metabolic Disorders,Oncology and Tumor Markers, |
| UNILABS | Switzerland | Private Company | Core laboratory testing,Medical imaging services,Pathology and centres of excellence, |
| BIO-RAD LABORATORIES, INC. | United States | Public Company | Clinical Diagnostics,Life Science Research Instruments and Reagents,Other and Services, |
| THERMO FISHER SCIENTIFIC, INC. | United States | Public Company | Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics, |
| ABBOTT | United States | Public Company | Diagnostic Products (core lab, rapid, molecular, cardiometabolic, drug testing),Medical Devices (cardiovascular, diabetes care, neuromodulation),Nutritional Products (pediatric, adult, infant formula), |
| LGC LIMITED | South Korea | Public Company | Ethylene-based synthetic resins (EVA, HDPE, LDPE, LLDPE, POE, metallocene PE, UNIQABLE),Styrene-based resins (ABS, ASA, EPS, PS, SAN),Polycarbonate and polypropylene, |
| SIEMENS HEALTHINEERS AG | Germany | Public Company | Imaging,Diagnostics,Varian (Oncology), |
| QUIDELORTHO CORPORATION | United States | Public Company | Labs (clinical chemistry and immunoassay),Transfusion Medicine,Point of Care (professional and OTC), |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicines),Diagnostics (clinical instruments and consumables), |
| SYSMEX CORPORATION | Japan | Public Company | Hematology analyzers and reagents (XN-Series, XN-V, ProCyte Dx),Coagulation systems and reagents,Blood gas, electrolyte, and urinalysis analyzers, |
| BIO-TECHNE CORPORATION | United States | Public Company | Protein Sciences reagents (cytokines, growth factors, antibodies, small molecules, sera, cell selection),Proteomic and protein analysis instruments and immunoassays,Diagnostics products, controls, calibrators, and assays, |
| MICROBIX BIOSYSTEMS INC. | Canada | Public Company | Antigen and test ingredient business,QAPs branded test controls and quality assessment products,DxTM viral transport medium, |
| GRIFOLS, S.A. | Spain | Public Company | Biopharma (plasma-derived medicines),Diagnostic,Bio Supplies, |
BIOMERIEUX S.A.
bioMérieux S.A. is a French public company founded in 1963 that employs 14,894 people. The company operates in the diagnostics and life sciences sector.
CEPHEID INC.
Cepheid Inc. is a private company founded in 1996 in the United States with 1,700 employees. The company specializes in molecular diagnostics and infectious disease testing.
IMMUCOR, INC.
Immucor, Inc. is a private company founded in 1982 in the United States with 1,125 employees. The company focuses on blood bank and transfusion diagnostics.
DIASORIN
DiaSorin is an Italian public company founded in 1968 with 3,242 employees. The company operates in the in vitro diagnostics sector.
UNILABS
Unilabs is a private company founded in 1987 in Switzerland with 1,897 employees. The company provides laboratory and diagnostic services.
BIO-RAD LABORATORIES, INC.
Bio-Rad Laboratories, Inc. is a public company founded in 1952 in the United States with 7,450 employees. The company develops and manufactures life science research and clinical diagnostics products.
THERMO FISHER SCIENTIFIC, INC.
Thermo Fisher Scientific, Inc. is a public company founded in 1956 in the United States with 125,000 employees. The company is a global leader in serving science with laboratory equipment, reagents, and analytical instruments.
ABBOTT
Abbott is a public company founded in 1888 in the United States with 115,000 employees. The company operates in diagnostics, medical devices, pharmaceuticals, and nutritional products.
LGC LIMITED
LGC Limited is a public company founded in 1947 in South Korea with 14,019 employees. The company provides testing, proficiency testing, and reference materials services.
SIEMENS HEALTHINEERS AG
Siemens Healthineers AG is a public company founded in 1896 in Germany with 72,369 employees. The company provides medical imaging, laboratory diagnostics, and point-of-care testing solutions.
QUIDELORTHO CORPORATION
QuidelOrtho Corporation is a public company founded in 1979 in the United States with 6,500 employees. The company develops and manufactures rapid diagnostic tests and molecular testing solutions.
DANAHER CORPORATION
Danaher Corporation is a public company founded in 1969 in the United States with 59,000 employees. The company operates across diagnostics, life sciences, and environmental and applied solutions segments.
SYSMEX CORPORATION
Sysmex Corporation is a public company founded in 1968 in Japan with 10,861 employees. The company manufactures hematology analyzers and other in vitro diagnostic systems.
BIO-TECHNE CORPORATION
Bio-Techne Corporation is a public company founded in 1976 in the United States with 3,100 employees. The company develops and manufactures life science tools and bioanalytical instruments.
MICROBIX BIOSYSTEMS INC.
Microbix Biosystems Inc. is a public company founded in 1988 in Canada with 100 employees. The company produces quality control materials and reference standards for diagnostics.
GRIFOLS, S.A.
Grifols, S.A. is a public company founded in 1909 in Spain with 25,000 employees. The company specializes in blood plasma derivatives and diagnostic products.
Countries within Asia Pacific - compare and drill down
| Country | 2025 size (native) |
|---|---|
| China | USD 157.4 Million |
| Japan | USD 103.9 Million |
| India | USD 58.6 Million |
| Australia | USD 16.4 Million |
| South Korea | USD 13.7 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Segmentation : Gain detailed insights into Asia Pacific's IVD Quality Control Market with country-level analysis of China, Japan, India, Australia, and South Korea, enabling targeted market entry and expansion strategies.
- Growth Opportunity Identification : Identify high-growth segments within Asia Pacific's developing diagnostic markets, particularly in India and emerging economies, where quality control adoption is accelerating alongside healthcare infrastructure expansion.
- Competitive Landscape Analysis : Understand competitive dynamics across Asia Pacific's diverse regulatory environments, from mature markets like Japan to rapidly evolving markets in India, informing product positioning and partnership strategies.
- Regulatory & Compliance Insights : Access region-specific regulatory requirements and quality standards across Asia Pacific countries, essential for navigating complex compliance frameworks and ensuring market-appropriate product offerings.
- Strategic Investment Planning : Leverage comprehensive market forecasts and CAGR projections through 2030 to make informed investment decisions and resource allocation across Asia Pacific's IVD Quality Control sector.
Frequently asked questions
What is the market size of IVD Quality Control in Rest Of Latin America?
Rest Of Latin America's IVD Quality Control Market is estimated at USD 18.9 million in 2025 and is forecast to reach USD 21.9 million by 2030.
What is the CAGR for Rest Of Latin America's IVD Quality Control Market?
Rest Of Latin America's IVD Quality Control Market is projected to grow at a CAGR of 3.0% from 2025 to 2030.
How does Rest Of Latin America compare to the global IVD Quality Control Market?
Rest Of Latin America's growth rate of 3.0% is lower than the global CAGR of 5.5%, indicating slower market maturation and adoption in the region.
What factors are driving growth in Rest Of Latin America's IVD Quality Control Market?
Rest Of Latin America's market growth is driven by regulatory compliance mandates, laboratory infrastructure modernization, and increasing demand for reliable diagnostic testing.
What challenges does Rest Of Latin America's IVD Quality Control Market face?
Rest Of Latin America faces challenges including limited healthcare budgets, lower awareness of quality control standards, and slower adoption of advanced diagnostic technologies compared to developed markets.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the global IVD quality controls market.
Exhaustive secondary research was done to collect information on the IVD quality controls market. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the IVD quality controls market.
The four steps involved in estimating the market size are as follows:
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenue. Here’s the breakdown of tiers: Tier 1 = > USD 100 million, tier 2 = USD 10 million to USD 100 million, and tier 3 = < USD 10 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the IVD quality controls market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size included the following:
Data Triangulation
After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
IVD quality controls are standardized materials used to monitor, evaluate, and ensure the accuracy, reliability, and precision of diagnostic testing processes in clinical laboratories. These controls are designed to mimic patient samples and are produced from human-derived matrices such as serum, plasma, urine, or whole blood. IVD quality controls provide a benchmark for validating test system performance, detecting errors, and ensuring regulatory compliance across diverse diagnostic platforms.
Stakeholders
- Senior Management
- End Users
- Finance/Procurement Department
- R&D Department
Report Objectives
- To define, describe, segment, and forecast the global IVD quality controls market by product & service, technology, manufacturer type, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall IVD quality controls market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies2
- To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
- To benchmark players within the IVD quality controls market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
- To study the impact of AI/Gen AI on the market, along with the macroeconomic outlook for each region
Get the Full In Vitro Diagnostics (IVD) Quality Control Market Report
Full forecast, segment splits, and company analysis for all In Vitro Diagnostics (IVD) Quality Control Market.
- Canada In Vitro Diagnostics (IVD) Quality Control Market
- US In Vitro Diagnostics (IVD) Quality Control Market
- Germany In Vitro Diagnostics (IVD) Quality Control Market
- UK In Vitro Diagnostics (IVD) Quality Control Market
- France In Vitro Diagnostics (IVD) Quality Control Market
- Italy In Vitro Diagnostics (IVD) Quality Control Market
- Spain In Vitro Diagnostics (IVD) Quality Control Market
- Russia In Vitro Diagnostics (IVD) Quality Control Market
- China In Vitro Diagnostics (IVD) Quality Control Market
- Japan In Vitro Diagnostics (IVD) Quality Control Market
- India In Vitro Diagnostics (IVD) Quality Control Market
- Australia In Vitro Diagnostics (IVD) Quality Control Market
- South Korea In Vitro Diagnostics (IVD) Quality Control Market
- Brazil In Vitro Diagnostics (IVD) Quality Control Market
- Mexico In Vitro Diagnostics (IVD) Quality Control Market
- Saudi Arabia In Vitro Diagnostics (IVD) Quality Control Market
- UAE In Vitro Diagnostics (IVD) Quality Control Market
- Rest Of Europe In Vitro Diagnostics (IVD) Quality Control Market
- Rest Of Asia Pacific In Vitro Diagnostics (IVD) Quality Control Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report